Susquehanna International Group’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Sell |
1,018,919
-566,729
| -36% | -$1.54M | ﹤0.01% | 1918 |
|
|
2025
Q1 | $5.38M | Buy |
1,585,648
+1,316,623
| +489% | +$4.46M | ﹤0.01% | 1146 |
|
|
2024
Q4 | $1.11M | Buy |
269,025
+249,155
| +1,254% | +$1.03M | ﹤0.01% | 2838 |
|
|
2024
Q3 | $49.5K | Sell |
19,870
-1,918
| -9% | -$4.78K | ﹤0.01% | 5291 |
|
|
2024
Q2 | $57.5K | Sell |
21,788
-77,990
| -78% | -$206K | ﹤0.01% | 5249 |
|
|
2024
Q1 | $206K | Buy |
99,778
+13,455
| +16% | +$27.7K | ﹤0.01% | 4657 |
|
|
2023
Q4 | $155K | Buy |
86,323
+29,747
| +53% | +$53.5K | ﹤0.01% | 5137 |
|
|
2023
Q3 | $77.5K | Buy |
56,576
+6,074
| +12% | +$8.32K | ﹤0.01% | 5006 |
|
|
2023
Q2 | $69.2K | Buy |
+50,502
| New | +$69.2K | ﹤0.01% | 5135 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6071 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6314 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5928 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5969 |
|
|
2021
Q2 | – | Sell |
-22,247
| Closed | -$238K | – | 5465 |
|
|
2021
Q1 | $238K | Buy |
+22,247
| New | +$238K | ﹤0.01% | 4607 |
|
|
2020
Q4 | – | Sell |
-953
| Closed | -$16K | – | 4874 |
|
|
2020
Q3 | $16K | Sell |
953
-68
| -7% | -$1.14K | ﹤0.01% | 4311 |
|
|
2020
Q2 | $8K | Buy |
+1,021
| New | +$8K | ﹤0.01% | 4162 |
|
|
2017
Q1 | – | Sell |
-124
| Closed | -$20K | – | 3542 |
|
|
2016
Q4 | $20K | Sell |
124
-322
| -72% | -$51.9K | ﹤0.01% | 4054 |
|
|
2016
Q3 | $111K | Buy |
+446
| New | +$111K | ﹤0.01% | 2687 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3390 |
|
|
2015
Q1 | – | Sell |
-147
| Closed | -$351K | – | 4186 |
|
|
2014
Q4 | $351K | Buy |
+147
| New | +$351K | ﹤0.01% | 3615 |
|